Platelet derived growth factor and subarachnoid haemorrage: A study on cisternal cerebrospinal fluid

Acta Neurochirurgica

Volumn 139, Issue 4, 1997, Pages 319-324

  Gaetani, P ^a,b   Tancioni, F ^a   Grignani, G ^a   Tartara, F ^a   Merlo, E M ^a   Brocchieri, A ^a   Rodriguez Y Baena, R ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Intracranial aneurysm; Platelet derived growth factor; Subarachnoid haemorrhage; Vasospasm

Indexed keywords

PLATELET DERIVED GROWTH FACTOR;

ARTICLE; BRAIN SURGERY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRACRANIAL ANEURYSM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOLOGY; STATISTICAL ANALYSIS; SUBARACHNOID HEMORRHAGE; SUBARACHNOID SPACE; SYMPTOM; VASOSPASM;

EID: 0030999034     PISSN: 00016268     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01808827     Document Type: Article

References (29)

1. Berk BC, Alexander RW, Brock TA, Gimbrone MA, Webb CR (1986) Vasoconstriction: a new activity for platelet-derived growth factor. Science 232: 87-90
2. Chan RC (1984) The role of the prostacyclin-thromboxane system in cerebral vasospasm following induced subarachnoid hemorrhage in the rabbit. J Neurosurg 61: 1120-1128
3. Fein JM, Flor WJ, Cohan SL, Parkhurst J (1974) Sequential changes of vascular ultrastructure in experimental vasospasm. J Neurosurg 41: 49-58
4. Fisher CM, Kistler JP. Davis JM (1980) Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6: 1-9
5. Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Koike T, Tanaka R (1995) Hemostasis in spontaneous subarachnoid hemorrhage. Neurosurgery 37: 226-234
6. Gaetani P, Marzatico F, Rodriguez y Baena R, Pacchiarini L, Viganò T, Grignani G. Crivellari MT, Benzi G (1990) Arachidonic acid metabolism and pathophysiological aspects of subarachnoid hemorrhage in rats. Stroke 21: 328-332
7. Gaetani P, Rodriguez y Baena R, Grignani G, Spanu G, Pacchiarini L, Paoletti P (1994) Endothelin and aneurysmal subarachnoid hemorrhage: a study of subarachnoid cisternal cerebrospinal fluid. J Neurol Neurosurg Psychiatry 57: 66-72
8. Habenicht AJR, Goerig M, Grulich J, Rothe D, Gronwald R, Loth U, Schettler G, Kommerell B, Ross R (1985) Human platelet-derived growth factor stimulates prostaglandin synthesis by activation and by rapid de novo synthesis of cyclooxygenase. J Clin Invest 75: 1381-1387
9. Honma Y, Kita T, Inomata S, Hasui K, Irie K, Nagao S (1993) The platelet-derived growth factor content in cerebrospinal fluid of patients with an aneurysmal subarachnoid hemorrhage. Jpn J Neurosurg (Tokyo) 2: 192-197
10. Honma Y, Kita T, Inomata S, Hasui K, Irie K, Nagao S, Clower BR, Smith RR (1993) Proliferative angiopathy following subarachnoid hemorrhage and platelet-derived growth factor. In: Findlay JM (ed) Cerebral vasospasm. Elsevier, Amsterdam, pp 257-260
11. Juvela S, Hillbom M, Kaste M (1991) Platelet thromboxane release and delayed cerebral ischemia in patients with subarachnoid hemorrhage. J Neurosurg 74: 386-392
12. Kapp JP, Neill WR, Neill CL, Hodges LR, Smith RR (1982) The three phases of vasospasm. Surg Neurol 18: 40-45
13. Kassel NF, Sasaki T, Colohan ART, Nazar G (1985) Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 16: 562-572
14. Kohler N, Lipton A (1974) Platelets as a source of fibroblast growth-promoting activity. Exp Cell Res 87: 297-301
15. Kurimoto M. Nishijima M, Hirashima Y, Endo S, Takaku A (1995) Plasma Platelet-derived Growth Factor-B chain is elevated in patients with extensively large brain tumour. Acta Neurochir (Wien) 137: 182-187
16. Nister M, Enblad P, Backstorm G, Soderman T, Persson L, Heldin CH, Westermark B (1994) Platelet-derived growth factor (PDGF) in neoplastic and non-neoplastic cystic lesions of the central nervous system and in the cerebrospinal fluid. Br J Cancer 69: 952-956
17. Ohkuma H, Suzuki S, Kimura M, Sobate E (1991) Role of platelet function in symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 22: 854-859
18. Paoletti P, Gaetani P, Grignani G, Pacchiarini L, Silvani V, Rodriguez y Baena R (1988) CSF leukotriene C4 following subarachnoid hemorrhage. J Neurosurg 69: 488-493
19. Rodriguez y Baena R, Gaetani P, Paoletti P (1988) A study on cisternal CSF levels of arachidonic acid metabolites after aneurysmal subarachnoid hemorrhage. J Neurol Sci 84: 329-335
20. Ross R, Raines EW, Bowen-Pope DF (1986) The biology of platelet-derived growth factor. Cell 46: 155-169
21. Sasaki T, Asano T, Takakura K, Sano K, Kassell NF (1984) Nature of the vasoactive substance in CSF from patients with subarachnoid hemorrhage. J Neurosurg 60: 1186-1194
22. Smith RR, Clower BR, Peeler DF, Yoshioka J (1983) The angiopathy of subarachnoid hemorrhage: angiographic and morphologic correlates. Stroke 14: 240-245
23. Suzuki S, Sobata E, Iwabuchi T (1981) Prevention of cerebral ischemic symptoms in cerebral vasospasm with Trapidil, an antagonist and selective synthesis inhibitor of thromboxane A2. Neurosurgery 9: 679-685
24. Suzuki M, Ogawa A, Sakurai Y, Nishino A, Uenohara K, Mizoi K, Yoshimoto T (1992) Thrombin activity in cerebrospinal fluid after subarachnoid hemorrhage. Stroke (letter) 23: 1181-1182
25. Yamamoto Y, Bernanke DH, Smith RR (1990) Accelerated non-muscle contraction after subarachnoid hemorrhage: cerebrospinal fluid testing in a culture model. Neurosurgery 27: 921-928
26. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki M (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415
27. Walker V, Pickard JD, Smythe P, Eastwood S, Perry S (1983) Effects of subarachnoid hemorrhage on intracranial prostaglandins. J Neurol Neurosurg Psychiatry 46: 119-125
28. Westermark B, Wasteson A (1974) A platelet factor stimulating human normal glial cells. Exp Cell Res 98: 170-174
29. Westphal M, Herrmann HD (1989) Growth factor biology and oncogene activation in human gliomas and their implication for specific therapeutic concepts. Neurosurgery 25: 681-694